Alisol G

Overview

Alisol G (25-Anhydroalisol A) is a human carboxylesterase 2 ( hCES2 ) inhibitor with an IC 50 of 3.85 μM. Alisol G exhibits cytotoxic activity against human cancer cells, anti bacterial activity against Gram-positive strains, and anti- hepatitis B virus activity. Alisol G can be used in research related to lung cancer , breast cancer , prostate cancer , bacterial infections, and HBV infections.

Application

Products | Products > Disease Areas > Hepatitis Virus Infection | Products > Disease Areas > Lung Cancer | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Bacterial Infection | Products > Disease Areas > HBV Reverse Transcriptase | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Urogenital Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Carboxylesterase (CES) | Products > Signaling Pathways > Bacterial | Products > Signaling Pathways > HBV

Product Information

• Catalog No.: HY-N0855
• CAS No.: 155521-46-3
• Molecular Formula: C30H48O4
• Molecular Weight: 472.70
• Purity: 98.13%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (5.29 mM); Clear solution
• Availability: In-stock

Source

Original product source